Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3774721012 | Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3774722017 | Dolutegravir and lamivudine only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) | Is a | Dolutegravir and lamivudine only product | true | Inferred relationship | Some | ||
Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) | Is a | Product containing dolutegravir and lamivudine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) | Has active ingredient | Dolutegravir | true | Inferred relationship | Some | 2 | |
Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) | Has active ingredient | Lamivudine (substance) | true | Inferred relationship | Some | 1 | |
Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set